Apple's $634M payment to Masimo now set in stone after Judge tosses appeal
Apple faces a final defeat in its long-running patent battle over proprietary pulse oximetry technology.
Apple's $634M payment to Masimo now set in stone after Judge tosses appeal AppleInsiderApple loses bid to overturn $634 million Masimo patent verdict, new trial also denied 9to5MacApple loses bid to overturn $634M Masimo judgment over Apple Watch dispute&nbs...
Google News AI
Source
Apple's $634M payment to Masimo now set in stone after Judge tosses appeal AppleInsiderApple loses bid to overturn $634 million Masimo patent verdict, new trial also denied 9to5MacApple loses bid to overturn $634M Masimo judgment over Apple Watch dispute MSNMasimo keeps $634m smartwatch award and moves to appeal World IP ReviewFull Fed. Circ. Won't Review Apple's ITC Loss Against Masimo Law360
Generated insight by OnAirToday AI
This ruling solidifies a significant legal defeat for Apple, underscoring the escalating intellectual property risks tech giants face when integrating advanced health-tracking sensors into wearables. It highlights a shift in judicial scrutiny toward patent disputes, signaling that billion-dollar hardware empires must navigate increasingly complex patent landscapes to avoid costly litigation outcomes.
Comments
Keep comments relevant and respectful. No links, advertising, self-promotion, or spam.